Essex Investment Management’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-31,225	Closed	-$649K	–	347
2017 Q1	$649K	Buy	31,225 +9,933	+47%	+$206K	0.1%	241
2016 Q4	$304K	Buy	+21,292	New	+$304K	0.05%	293